Figure 5From: Continued improvement of cardiovascular mortality in Hungary - impact of increased cardio-metabolic prescriptions The increase of annual prescriptions rate per 10 000 inhabitant for antihypertensive (A), antilipidemic (B) and antidiabetic (C) drugs between 2000 and 2008 in Hungary 4 Back to article page